Greek track sprinter positive in re-analysis of 2016 Olympics samples

Christos Volikakis on the podium of the Men's Scratch Race during the 2019 UCI Track Cycling World Cup in Hong Kong
Christos Volikakis on the podium of the Men's Scratch Race during the 2019 UCI Track Cycling World Cup in Hong Kong (Image credit: Getty Images)

The UCI announced that it has provisionally suspended Greek track sprinter Christos Volikákis, 36, after he tested positive for an experimental drug, Ligandrol (LGD-4033), in the re-analysis of doping controls taken at the 2016 Olympic Games in Rio de Janeiro, Brazil.

Ligandrol is a selective androgen receptor modulator (SARM), a class of drugs that activate androgen receptors, providing the same benefits as anabolic steroids without the side effects on reproductive organs. SARMs are prohibited substances under class S1.2 (Other Anabolic Agents) of the Prohibited List.

Latest Videos From
Laura Weislo
Managing Editor

Laura Weislo is a Cyclingnews veteran of 20 years. Having joined in 2006, Laura extensively covered the Operacion Puerto doping scandal, the years-long conflict between the UCI and the Tour de France organisers ASO over the creation of the WorldTour, and the downfall of Lance Armstrong and his lifetime ban for doping. As Managing Editor, Laura coordinates coverage for North American events and global news.